Casdin Capital’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,250
Closed -$452K 46
2022
Q2
$452K Sell
11,250
-78,750
-88% -$5.75M 0.04% 38
2022
Q1
$9.63M Hold
90,000
0.43% 36
2021
Q4
$22.4M Buy
+90,000
New +$20M 0.63% 33

Other funds holding SNCE

Casdin Capital's SNCE Position: Q3 2022 in Review

Casdin Capital sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2022, closing a stake of 11,250 shares — an estimated $452K sold.

Casdin Capital first reported a position in SNCE in Q4 2021 and held it in 3 quarters. The position peaked at $22.4M in Q4 2021. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

  • Casdin Capital reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Casdin Capital sold 11,250 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $452K.
  • Casdin Capital first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Casdin Capital's Science 37 Holdings, Inc. Common Stock position peaked at $22.4M in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on Casdin Capital's 13F filing for Q3 2022, filed 14 Nov 2022.